Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ)
300519.SZ Stock Price Chart
Explore Zhejiang Xinguang Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 300519.SZ price movements and trends.
300519.SZ Company Profile
Discover essential business fundamentals and corporate details for Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
24 Jun 2016
Employees
315.00
Website
https://www.xgpharma.comCEO
Yue Jun Wang
Description
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health foods. The company offers pharmaceutical products in the areas of cardiovascular and cerebrovascular diseases, and traumatic diseases, covering the aspects of respiratory system, digestive system, urinary system, pediatric diseases, and improving immunity. It also can produce 6 dosage forms with 49 approval numbers for drug production and 2 approval numbers for health food. It offers its products in the form of tablets, granules, syrups, powders, hard capsules, and oral solutions, as well as mixtures, including oral liquids. Zhejiang Xinguang Pharmaceutical Co., Ltd. was founded in 1970 and is headquartered in Shengzhou, China.
300519.SZ Financial Timeline
Browse a chronological timeline of Zhejiang Xinguang Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 28 May 2025
A dividend of ¥0.30 per share was announced, adjusted to ¥0.30. The dividend was paid on 28 May 2025.
Earnings released on 16 May 2025
EPS came in at ¥0.08 , while revenue for the quarter reached ¥51.45M .
Earnings released on 31 Mar 2025
EPS came in at ¥0.15 , while revenue for the quarter reached ¥93.25M .
Earnings released on 30 Sept 2024
EPS came in at ¥0.08 , while revenue for the quarter reached ¥70.00M .
Earnings released on 30 Jun 2024
EPS came in at ¥0.02 , while revenue for the quarter reached ¥44.98M .
Dividend declared on 29 May 2024
A dividend of ¥0.40 per share was announced, adjusted to ¥0.40. The dividend was paid on 29 May 2024.
Earnings released on 17 May 2024
EPS came in at ¥0.03 , while revenue for the quarter reached ¥54.29M .
Earnings released on 31 Mar 2024
EPS came in at ¥0.14 , while revenue for the quarter reached ¥98.90M .
Earnings released on 30 Sept 2023
EPS came in at ¥0.13 , while revenue for the quarter reached ¥67.08M .
Earnings released on 30 Jun 2023
EPS came in at ¥0.05 , while revenue for the quarter reached ¥56.74M .
Dividend declared on 30 May 2023
A dividend of ¥0.50 per share was announced, adjusted to ¥0.50. The dividend was paid on 30 May 2023.
Earnings released on 31 Mar 2023
EPS came in at ¥0.19 , while revenue for the quarter reached ¥92.30M .
Earnings released on 1 Jan 2023
EPS came in at ¥0.12 , while revenue for the quarter reached ¥89.04M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.18 , while revenue for the quarter reached ¥91.99M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.11 , while revenue for the quarter reached ¥68.57M .
Dividend declared on 26 May 2022
A dividend of ¥0.60 per share was announced, adjusted to ¥0.60. The dividend was paid on 26 May 2022.
Earnings released on 31 Mar 2022
EPS came in at ¥0.27 , while revenue for the quarter reached ¥101.90M .
Earnings released on 31 Dec 2021
EPS came in at ¥0.16 , while revenue for the quarter reached ¥74.61M .
Earnings released on 30 Sept 2021
EPS came in at ¥0.19 , while revenue for the quarter reached ¥86.77M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.11 , while revenue for the quarter reached ¥63.38M .
Dividend declared on 28 May 2021
A dividend of ¥0.60 per share was announced, adjusted to ¥0.60. The dividend was paid on 28 May 2021.
Earnings released on 28 Apr 2021
EPS came in at ¥0.15 , while revenue for the quarter reached ¥70.50M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.24 , while revenue for the quarter reached ¥96.12M .
Earnings released on 30 Sept 2020
EPS came in at ¥0.18 , while revenue for the quarter reached ¥84.15M .
300519.SZ Stock Performance
Access detailed 300519.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.